Zoetis Inc.
XETRA: ZOE.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Kristin C. Peck
- Employees
- 13,800
- Headquarters
- Parsippany, United States
- IPO year
- 2019
- Market cap
- €29.4B
- Website
- https://www.zoetis.com
Loading ZOE…
Loading profile data…Frequently asked questions about ZOE
What does Zoetis Inc. (ZOE.DE) do?
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses....
Where does ZOE.DE trade?
Zoetis Inc. (ZOE.DE) trades on the Deutsche Börse.
What sector is ZOE.DE in?
Zoetis Inc. (ZOE.DE) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zoetis Inc.?
Kristin C. Peck is the chief executive officer of Zoetis Inc. (ZOE.DE).
Where is Zoetis Inc. headquartered?
Zoetis Inc. is headquartered in United States.
Does ZOE.DE pay a dividend?
Yes — Zoetis Inc. (ZOE.DE) paid a trailing twelve-month dividend of EUR 1.75 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ZOE.DE go public?
Zoetis Inc. (ZOE.DE) completed its initial public offering in 2019.